Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors associated with poor fetal outcome in placental abruption.
de Moreuil C, Hannigsberg J, Chauvet J, Remoue A, Tremouilhac C, Merviel P, Bellot C, Pan Petesch B, Le Moigne E, Lacut K, Marcorelles P. de Moreuil C, et al. Among authors: remoue a. Pregnancy Hypertens. 2021 Mar;23:59-65. doi: 10.1016/j.preghy.2020.11.004. Epub 2020 Nov 25. Pregnancy Hypertens. 2021. PMID: 33264704 Free article.
[A NTRK1-rearranged mammary carcinoma].
Remoué A, Conan-Charlet V, Le Flahec G, Lambros L, Marcorelles P, Uguen A. Remoué A, et al. Ann Pathol. 2020 Jan;40(1):42-45. doi: 10.1016/j.annpat.2019.05.009. Epub 2019 Jun 26. Ann Pathol. 2020. PMID: 31253456 French. No abstract available.
PD-L1 Immunohistochemistry-Discrepant Results Between Synchronous Tumor Samples May Cause More Treatment Choice Dilemmas Than Molecular Heterogeneity in Patients With Advanced Non-Small Cell Lung Cancers.
Lambros L, Quintin-Roué I, Bourhis A, Remoué A, Le Flahec G, Marcorelles P, Uguen A. Lambros L, et al. Among authors: remoue a. Appl Immunohistochem Mol Morphol. 2020 Jul;28(6):437-443. doi: 10.1097/PAI.0000000000000768. Appl Immunohistochem Mol Morphol. 2020. PMID: 31498156
Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A. Bourhis A, et al. Among authors: remoue a. Pathology. 2022 Feb;54(1):55-62. doi: 10.1016/j.pathol.2021.05.100. Epub 2021 Sep 10. Pathology. 2022. PMID: 34518039
11 results